Research on the biomarkers for differential diagnosis between VaD and AD mainly includes biochemical, genomics, proteomics, and neurophysiology markers such as neurofilament light unit and neurofilament protein levels (23), the ratio of plasma Aβ-38/-40 peptides (24), and phosphorylated tau proteins (25). Here, MAPT is linked to Alzheimer disease.